person · Reporting owner
KRATOCHVIL DAVID MATTHEW
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nixxy, Inc.NIXX · Entity 7730 | Director | January 16, 2025 | January 31, 2025 |
| VOLITIONRX LTDVNRX · Entity 8241 | Chief Financial Officer | October 05, 2016 | October 06, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nixxy, Inc.
Report date January 16, 2025 · Filed January 31, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units ("RSUs")SEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2025-01-16 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance Not disclosed F3: Each of the RSU represents a contingent right to receive one (1) share of the Issuer's common stock, par value $0.0001 per share upon settlement. F1: The RSU were issued to the Reporting Person under the Issuer's 2021 Equity Incentive Plan in connection with the Reporting Person's appointment as a member of the board of directors of the Issuer. F2: 50,000 of the RSUs vested immediately, and the remaining 50,000 RSUs shall vest in 36 equal increments on a monthly basis, subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The RSU were issued to the Reporting Person under the Issuer's 2021 Equity Incentive Plan in connection with the Reporting Person's appointment as a member of the board of directors of the Issuer.
F2: 50,000 of the RSUs vested immediately, and the remaining 50,000 RSUs shall vest in 36 equal increments on a monthly basis, subject to the Reporting Person's continued service to the Issuer.
F3: Each of the RSU represents a contingent right to receive one (1) share of the Issuer's common stock, par value $0.0001 per share upon settlement.
VOLITIONRX LTD
Report date October 05, 2016 · Filed October 06, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
After 2016-10-05 transaction · row 1
1 source rowRow 1 · 2016-10-05 · Purchase · Acquired 10,000 · Balance 10,000 F1: These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2016 Filed Oct 6, 2016 16:31 UTC | VOLITIONRX LTD VNRX · Entity 8241 | PurchaseCommon Stock | 10,000 | $5.00 | $50,000.00 |
DisclosureSEC source: 0001078782-16-003581 · primary_doc.xml · nonDerivative · entry 1 KRATOCHVIL DAVID MATTHEW · CIK 0001650670 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 20:27 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001078782-16-003481 · primary_doc.xml · derivative · entry 1 KRATOCHVIL DAVID MATTHEW · CIK 0001650670 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-09-13 F1 · derivative.exercise_date: A total of 25,000 Options were granted on September 13, 2016 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.